We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Investigational records were not retained for a period of two years following approval of a drug's
marketing application and discontinuance of the investigation and notification of FDA.